Briefing

Industry news

Covid-19 briefing

Industry briefing

NEWS

Samsung Biologics signs Covid-19 therapy manufacturing deal with Eli Lilly

COVID-19

IMF revises 2020 global GDP forecast to -4.4%

IMF has revised it's 2020 global GDP forecast to -4.4%

BRIEFING

Novartis’ Ilaris fails in late-stage Covid-19 trial

Novartis’ Ilaris has failed to produce results in a Phase III trial

Industry news

Covid-19 briefing

Industry briefing

02/24/2024 10:38:17
  • Home | The logistics of delivering a global vaccine
  • In this issue
  • Contents
  • Mimotopes
  • SHL Medical
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Solvias Company Insight
  • Solvias
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Swiftpak
  • Comment
  • Long HCC pipeline marks change for a previously stagnant market
  • Pfizer and BioNTech’s Covid-19 vaccine candidate shows 90% efficacy
  • Blockchain-enabled hospital can provide real-world data
  • The increasing influence of industry sponsors along the pandemic timeline
  • Digitalisation in pharmaceutical manufacturing
  • VEGA Australia
  • Kugelmeiers
  • Unither Pharmaceuticals
  • In Depth
  • Special delivery: the logistics of curing Covid-19
  • Will there ever be an HIV vaccine?
  • Predicting Covid-19 vaccine approvals with Opyl
  • Unequal access: understanding cancer treatment disparity in Europe
  • ‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?
  • Q&A: investing in innovative biotechs with Novo Ventures
  • Gold standard: why are Phase III trials so critical?
  • Brewprint: using yeast to make plant-based drugs
  • Air France
  • Zenatek Company Insight
  • In Data
  • Inside the deal
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
11/18/2020 00:00:00